Close menu




December 16th, 2020 | 10:33 CET

DOW, Henkel, Royal Helium - Chemistry learns sustainability

  • Investments
Photo credits: pixabay.com

The chemical sector is entering a new era. Value chains are being reshaped as sustainability, along with economic and geopolitical shifts, new technologies, and changing consumer demands challenge the bottom line and future profitability of companies. Covid-19 has led to even greater complexity and caused significant shifts in supply and demand. However, sustainability factors and ESG criteria also offer growth and differentiation opportunities for companies that redefine their value chains and business models, adapt to the circular economy, seize the opportunities of digital technology, and upskill their employees to the best of their abilities.

time to read: 3 minutes | Author: André Will-Laudien
ISIN: CA78029U2056 , DE0006048432 , US2605571031

Table of contents:


    Dow Inc.- chemical giant on new paths

    Dow Inc., formerly known as Dow Chemical, recently announced that it has joined with companies from around the world to form a new consortium under the acronym CELAB: "Toward a Circular Economy for Labels." CELAB is a well-intentioned industry initiative started by self-adhesive label manufacturers with the goal of creating a greater circular economy for their products by improving and promoting the recycling of matrix and release paper substrates.

    With the formation of CELAB, Dow joins other industry leaders to facilitate collaboration on a global scale, promote regional initiatives and implement universal adoption of industry best practices for greater sustainability. Success is guaranteed through the collaboration between industry players across the value chain. Dow Inc. is the 2019 merger of Dow Chemical and Du Pont de Nemours, which currently employs 37,000 people in agricultural chemicals, plastics and speciality chemicals.

    With a price-to-sales ratio of just 1 and a dividend yield of 5.3%, Dow Inc. is an absolute standard old economy stock. With a share price of USD 53.7, it is aiming for new highs in a positive trend.

    Henkel - Washing 4.0

    Henkel has opened a state-of-the-art, fully automated warehouse for laundry detergents and household cleaners at its production site in Montornès del Vallès, in Spain near Barcelona. The Company made an investment of EUR 22 million in the 24,000-square-meter warehouse, which will serve as an essential distribution hub for southern Europe. The new logistics centre is another example of Henkel's strategy to combine Industry 4.0 and smart factory concepts. The facility will be based on digitization and robotization. It will use cutting-edge technology in logistics and will define new environmental standards. In this way, the Company is improving the resource efficiency of its supply chain, time-to-market and streamlining processes. Henkel aims to become a climate-neutral company by 2040.

    Henkel's share price recovery is still a long way from the 2017 highs of around EUR 125, with the share price recently rising from EUR 68 to EUR 89. However, earnings growth is expected to return to 15% in 2021. In the last 3 years, this had slumped by almost 40%. The Company has a market value of EUR 39 billion and is currently practicing breaking out of a three-year downtrend. With a target price of EUR 106, Goldman Sachs is already positive - we hope this is a good sign…

    Royal Helium - With full cash into the new year

    Royal Helium Ltd. is focused on the exploration and development of a significant helium production project in southern Saskatchewan. Helium is an essential industrial gas for the chemical industry. With over 400,000 hectares of prospective land held under permits, leases and applications, Royal is one of the largest helium landholders in North America.

    Royal Helium's projects have been methodically studied for over two years for their production potential and reviewed by geologists and engineers. A feasibility study will now be carried out, and the project will be developed further, as the demand for helium has grown by leaps and bounds. To take the next steps, RHI has entered into an agreement with a consortium of underwriters led by Cormark Securities Inc. for a private placement of 20 million units at a price of 22 cents per unit. This amount flushes around CAD 5 million into the coffers, which means that the Company is financed through for the future work and can tackle the year 2021 dynamically.

    The Company currently has a capitalization of only CAD 15.2 million at a price of CAD 0.26 per share. The outlook remains very promising, not least because there are currently only a few new helium developments, and demand is leading to rising prices. Potential buyers are likely to have already positioned themselves in the recent capital increase.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    André Will-Laudien

    Born in Munich, he first studied economics and graduated in business administration at the Ludwig-Maximilians-University in 1995. As he was involved with the stock market at a very early stage, he now has more than 30 years of experience in the capital markets.

    About the author



    Related comments:

    Commented by André Will-Laudien on January 31st, 2023 | 14:50 CET

    E-mobility 2023: The Tesla hunters are coming! BYD, Lucid Motors, Tocvan Ventures. Will the Varta share now also fly?

    • Mining
    • Gold
    • Electromobility
    • Investments

    It Is hard to believe! The Tesla share is once again making a name for itself. Analysts went into the presentation of the annual figures with cautious expectations because there were many negative rumors surrounding Elon Musk's electronics company: Fewer sales? Cars on stockpile? Again, it came as no one had expected it. Elon Musk delivered and simultaneously mocked all the shorties who wanted to push his stock below USD 100 at the turn of the year. This gambit went badly wrong because Tesla was able to deliver even better figures than expected, and there was no stopping the share. With plus 70% in only 4 weeks, the Tesla share belongs to the shooting stars since the turn of the year - the short sellers must have lost their desire completely. But the variety of interesting shares is significant. Where are the opportunities for e-investors lurking?

    Read

    Commented by Nico Popp on January 31st, 2023 | 14:33 CET

    This new project changes everything: Deutsche Bank, Aspermont, Alibaba

    • Digitization
    • Innovations
    • Technology
    • Investments

    When processes go digital, great opportunities arise: automation and scaling can ensure growth and turn established business models into high-flyers. But which companies should investors actively support in their transformation? Where is there real potential for investors, and where are companies just spreading buzzwords? We highlight three stocks for you.

    Read

    Commented by André Will-Laudien on January 30th, 2023 | 09:13 CET

    Mega biotech rally 2023! Defence Therapeutics, Bayer, BioNTech, Morphosys - Where to put the money?

    • Biotechnology
    • Cancer
    • Covid19
    • Investments

    Who would have thought it? Since the beginning of the year, the stock markets have been jubilant despite difficult predictions about the economic trend in 2023. High inflation and rising interest rates are not a good breeding ground for the popular biotech stocks because they have to constantly refinance their research expenses. As the risk fee is readjusted as costs rise, investors demand higher premiums for providing money. However, some biotech stocks have taken off since the beginning of the year despite adverse conditions. What is their secret?

    Read